![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChemCID | |
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C10H12ClFN2 |
Molar mass | 214.67 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Chloro-4-fluorophenylpiperazine (3,4-CFP,Kleferein) is apsychoactive drug of thephenylpiperazine class. It has been sold as adesigner drug, first being identified in Poland in 2019.[1]